| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2009 | US7557108 e.g. (1-cyclopentylmethyl-1H-indol-5-yl)-(4-isopropyl-piperazin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor; antidepressant, anxiolytic agent; obesity, cardiovascular disorders |
| 07/07/2009 | US7557107 tricyclic compounds such as 4-{8-Chloro-6-[[(1-methoxy-cyclopropanecarbonyl)-amino]-(3-methyl-3H-imidazol-4- yl)-methyl]-11H-benzo[5.6]cyclohepta[1,2-b]pyridin-11-yl}-piperazine-1-carboxylic acid isopropyl ester, used as enzyme inhibitors for treatment of cancers |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7557105 Proliferative disorders; cancer; 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 07/07/2009 | US7557104 inhibitors of one or more protein kinases, such as CHK1, CHK2, VEGF (VEGF-R2), Pim-1, CDKs or CDK/cyclin complexes and both receptor and non-receptor tyrosine kinases; imidazo[1,2-a]pyrazines; cancer, inflammation, arthritis, viral, neurodegenerative, Alzheimer's disease, cardiovascular, fungal diseases |
| 07/07/2009 | US7557102 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses |
| 07/07/2009 | US7557101 4,5,6,7-tetrahydro-thieno[3,2-c] pyridine derivatives |
| 07/07/2009 | US7557100 Antibacterial agents |
| 07/07/2009 | US7557099 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
| 07/07/2009 | US7557098 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 07/07/2009 | US7557097 solid form; aminosteroid disulfate derivatives; petromyzonamine disulfate |
| 07/07/2009 | US7557096 stilbene phosphate derivatives; anticarcinogenic agents; bactericide, fungicide; veterinary medicine |
| 07/07/2009 | US7557095 Therapeutic compounds |
| 07/07/2009 | US7557094 Complex of chitosan, conjugated linoleic acid, vitamin a and cyclodextrin |
| 07/07/2009 | US7557093 Adenosine 5-monophosphate and uridine 5-monophosphate; |
| 07/07/2009 | US7557092 P2X and P2Y purinergic receptor agonists/antagonists |
| 07/07/2009 | US7557091 HKI10311129, novel antibiotic, method for producing the same and the use thereof |
| 07/07/2009 | US7557090 administering with a DNA damaging agent; modified alkyl-aromatic ring substitutions on the C-3' of the sugar moiety or alkyl-aromatic ring substitutions at the C-4' of the sugar; cytotoxicity; antitumor, anticarcinogenic agents; multidrug resistance; compounds act by intercalating with DNA |
| 07/07/2009 | US7557089 Use of derivatives of succinate esters for the treatment of dementia |
| 07/07/2009 | US7557087 Treating or preventing vascular condition in patient by administering locally a therapeutically effective amount of a composition that increases metabolic production of nitric oxide by nitric oxide synthases; treatment of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease |
| 07/07/2009 | US7556948 Method for producing crystallized pleuromutilins |
| 07/07/2009 | US7556931 Furosemide modulators of HM74 |
| 07/07/2009 | US7556926 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 07/07/2009 | US7556831 Administering polymeric proanthocyanidin composition such as crofelemer from a Croton species or Calophyllum species; treatment of diarrhea |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | US7556824 Transdermal patch comprising hydralazine derivative antioxidant and isosorbide di- and/or mononitrate |
| 07/07/2009 | US7556823 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 07/07/2009 | US7556806 High mannose oligosaccharide cluster used to induce an immune response for increasing production of 2G12 antibodies |
| 07/07/2009 | US7556799 removing potassium from the gastrointestinal tract with a potassium-binding polymer; an alpha-fluoroacrylic acid polymer, or a difluoromaleic acid polymer crosslinked with vinylsulfonic acid, acrylic acid, vinyl phosphonate, vinyl-1,1-bisphosphonate, vinyl sulfonate, vinyl-1,2-disulfonate, itaconic aci |
| 07/07/2009 | US7556798 Single, breath-activated step of delivering a drug to the pulmonary system by inhaling dry powder particles as carriers for adhered, adsorbed or chemically-combined bioactive agents; 50% of stored particle mass delivered; 5 milligrams of drug delivered; antiagglomerants; asthma; cyctic fibrosis |
| 07/07/2009 | US7556797 Absorption, fluorescence of light; diagnosis of kidney, heart diseases |
| 07/07/2009 | US7556150 Dispenser for progestin used for acute and maintenance treatment of DUB |
| 07/07/2009 | CA2566684C Pharmaceutical nitrones |
| 07/07/2009 | CA2518195C Antitumor effect potentiator and antitumor agent |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2461510C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2425876C Piperidine derivatives as antagonists of tachykinins |
| 07/07/2009 | CA2422711C Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists |
| 07/07/2009 | CA2420712C Fast release cefuroxime axetil compositions |
| 07/07/2009 | CA2406790C Sustained release formulations |
| 07/07/2009 | CA2406119C Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 07/07/2009 | CA2405892C Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 07/07/2009 | CA2405518C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 07/07/2009 | CA2380128C Plasters containing 4-biphenylacetic acid |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/07/2009 | CA2368165C Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 07/07/2009 | CA2345353C Null igf for the treatment of cancer |
| 07/07/2009 | CA2342628C The use of r-flurbiprofen for the treatment of inflammation |
| 07/07/2009 | CA2158479C Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome |
| 07/04/2009 | CA2648836A1 New derivatives of 1h-indol-1-urea, a process for their preparation and pharmaceutical compositions containing them |
| 07/03/2009 | CA2618278A1 Ipac derivatives and uses thereof |
| 07/03/2009 | CA2615200A1 Use of alkylphthalides for inducing phase 2 proteins |
| 07/02/2009 | WO2009082735A1 Melanins synthesized chemically or via enzyme catalysis |
| 07/02/2009 | WO2009082720A2 Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists |
| 07/02/2009 | WO2009082701A1 Hcv protease inhibitors and uses thereof |
| 07/02/2009 | WO2009082698A1 Compositions for treatment of cognitive disorders |
| 07/02/2009 | WO2009082697A1 Hcv protease inhibitors and uses thereof |
| 07/02/2009 | WO2009082691A1 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 07/02/2009 | WO2009082687A1 Azaindolizines and methods of use |
| 07/02/2009 | WO2009082680A1 Induced viscosity nutritional emulsions comprising a carbohydrate-surfactant complex |
| 07/02/2009 | WO2009082662A1 Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia |
| 07/02/2009 | WO2009082526A2 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 07/02/2009 | WO2009082478A1 Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
| 07/02/2009 | WO2009082471A1 Stable laquinimod preparations |
| 07/02/2009 | WO2009082459A2 Anti-aging composition containing resveratrol and method of administration |
| 07/02/2009 | WO2009082452A1 Pre-surgical treatment |
| 07/02/2009 | WO2009082437A2 Selective androgen receptor modulators (sarms) and uses thereof |
| 07/02/2009 | WO2009082426A1 Method of stimulating the motility of the gastrointestinal system using ipamorelin |
| 07/02/2009 | WO2009082363A1 Method and preparations for treating infection-allergic diseases |
| 07/02/2009 | WO2009082359A1 Extended release gliclazide tablet |
| 07/02/2009 | WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy |
| 07/02/2009 | WO2009082346A1 New acetyl coenzyme a carboxylase (acc) inhibitors and uses in treatments of obesity and diabetes mellitus - 087 |
| 07/02/2009 | WO2009082342A1 Steroid derivatives acting as glucocorticosteroid receptor agonists |
| 07/02/2009 | WO2009082268A2 LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
| 07/02/2009 | WO2009082227A1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
| 07/02/2009 | WO2009082216A1 Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota |
| 07/02/2009 | WO2009082214A1 Use of non-digestible carbohydrates for improving intestinal microbiota |
| 07/02/2009 | WO2009082203A1 Liquid nucleotides/nucleosides-containing product |
| 07/02/2009 | WO2009082185A1 Skin-whitening agent containing platycodin d |
| 07/02/2009 | WO2009082183A2 Vitamin c and vitamin e as an expression enhancer of tyrosine hydroxylase and nurrl for increasing a productivity of dopamine in ventral mesencephalon |
| 07/02/2009 | WO2009082124A2 Pharmaceutical composition for the treatment and prevention of glaucoma |
| 07/02/2009 | WO2009082039A1 Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ |
| 07/02/2009 | WO2009082038A2 Ampa receptor antagonists and zonisamide for epilepsy |
| 07/02/2009 | WO2009081970A1 Process for production of heterocycle-substituted pyridine derivative |
| 07/02/2009 | WO2009081957A1 Pyripyropene derivative having acat2-inhibiting activity |
| 07/02/2009 | WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those |
| 07/02/2009 | WO2009081891A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 07/02/2009 | WO2009081837A1 Pharmaceutical composition for ameliorating lower urinary tract symptom |
| 07/02/2009 | WO2009081833A1 Dried microorganism cell or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine, and method for production of the dried microorganism cell or microorganism extract |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081782A1 N-pyrazole-2-pyridinecarboxamide derivative |
| 07/02/2009 | WO2009081751A1 Novel method for producing antibiotic preparation |
| 07/02/2009 | WO2009081611A1 Antibacterial agent and composition for the oral cavity, food and drink containing the same |
| 07/02/2009 | WO2009081587A1 External preparation for skin |
| 07/02/2009 | WO2009081581A1 Composition for treatment or prevention of atopic dermatitis |
| 07/02/2009 | WO2009081564A1 DAPKs INHIBITOR |
| 07/02/2009 | WO2009081411A2 Nitric oxide generation to treat female sexual dysfunction |